COVID-19 Treatment at a Glance
PDF
Cite
Share
Request
Review
VOLUME: 21 ISSUE: 6
P: 438 - 445
November 2020

COVID-19 Treatment at a Glance

Turk Thorac J 2020;21(6):438-445
1. Department of Internal Medicine, Intensive Care Unit, Yüzüncü Yıl University, Dursun Odabaş Medical Center, Van, Turkey
2. Department of Chest Diseases, Recep Tayyip Erdoğan University School of Medicine, Rize, Turkey
3. Department of Chest Diseases, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Turkey
4. Department of Chest Diseases, Ufuk University School of Medicine, Ankara, Turkey
5. Department of Occupational Health and Diseases, Adana City Research and Training Hospital, Adana, Turkey
6. Department of Chest Diseases, Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Turkey
7. Department of Chest Diseases, Kütahya University of Health Sciences School of Medicine, Kütahya, Turkey
8. Department of Pediatric Pulmonology, Gazi University School of Medicine, Ankara, Turkey
9. Department of Pediatric Pulmonology, Hacettepe University School of Medicine, Ankara, Turkey
10. Clinic of Chest Diseases, Kırıkhan State Hospital, Hatay, Turkey
11. Department of Occupational Health and Diseases, Ankara Occupational and Environmental Diseases Hospital, Ankara, Turkey
12. Department of Chest Diseases, Hacettepe University School of Medicine, Ankara, Turkey
13. Department of Internal Medicine, Hacettepe University School of Medicine, Unit of Intensive Care, Ankara, Turkey
14. Clinic of Chest Diseases, Bilecik State Hospital, Bilecik, Turkey
15. Department of Chest Diseases, Başkent University School of Medicine, Ankara, Turkey
16. Department of Pediatric Pulmonology, Ankara Training and Research Hospital, Ankara, Turkey
17. Department of Chest Diseases, Denizli State Hospital, Denizli, Turkey
18. Department of Chest Diseases, Allergy and Immunology, Uludağ University School of Medicine, Bursa, Turkey
19. Clinic of Chest Diseases, Ardahan State Hospital Ardahan, Turkey
20. Department of Pathology, Ankara University, School of Medicine, Ankara, Turkey
21. Department of Chest Diseases, Kahramanmaraş Afşin State Hospital, Kahramanmaraş, Turkey
22. Department of Chest Diseases, Düzce University, School of Medicine, Düzce, Turkey
23. Clinic of Chest Diseases, Siirt State Hospital, Siirt, Turkey
24. Department of Intensive Care Unit, Suat Seren Chest Diseases and Thoracic Surgery Training and Research Hospital, İzmir, Turkey
25. Department of Physiotherapy and Rehabilitation, Yeditepe University, School of Health Sciences, İstanbul, Turkey
26. Department of Nursing, Yeditepe University, School of Health Sciences, İstanbul, Turkey
27. Department of Chest Diseases, İstanbul Cerrahpasa University, Cerrahpaşa School of Medicine, İstanbul, Turkey
28. Department of Medical Biology, University of Health Sciences, School of Medicine, İstanbul, Turkey
29. Department of Chest Diseases, Pamukkale University School of Medicine, Denizli, Turkey
30. Department of Chest Diseases, Osmangazi University School of Medicine, Eskişehir, Turkey
31. Clinic of Chest Diseases, Ünye State Hospital, Ordu, Turkey
32. Department of Chest Diseases, Düzce University School of Medicine, Düzce, Turkey
33. Department of Chest Diseases, Atatürk University School of Medicine, Erzurum, Turkey
No information available.
No information available
Accepted Date: 09.12.2020
Online Date: 09.12.2020
Publish Date: 09.12.2020
PDF
Cite
Share
Request

Abstract

As coronavirus disease 2019 (COVID-19) spreads across the world, the ongoing clinical trials are leading to a big race worldwide to develop a treatment that will help control the pandemic. Unfortunately, COVID-19 does not have any known effective treatment with reliable study results yet. In this pandemic, there is not a lot of time to develop a new specific agent because of the rapid spread of the disease. The process of developing a vaccine is long and requires hard work. Although the pathophysiology of the disease is not fully understood, some of the proposed treatment alternatives are based on old evidence and some have been used with the idea that they might work owing to their mechanism of action. The efficacy, reliability, and safety of the currently available treatment alternatives are therefore a matter of debate. Currently, the main therapies used in the treatment of COVID-19 are antiviral drugs and chloroquine/hydroxychloroquine. Other proposed options include tocilizumab, convalescent plasma, and steroids, but the mainstay of the treatment in intensive care units remains supportive therapies.

Cite this article as:

Arıkan H, Karadoğan D, Tokgöz Akyıl F, et al. COVID-19 treatment at a glance. Turk Thorac J 2020; 21(6): 438-45.

Keywords:
Coronavirus disease 2019, treatment, hydroxychloroquine, tocilizumab, convalescent plasma